The Vascular Effects of Vildagliptin in Insulin Resistant Individuals

NCT01122641 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Insulin Resistance
Microvascular Disease

Interventions

DRUG: Vildagliptin
DRUG: Placebo

Sponsor

Royal Devon and Exeter NHS Foundation Trust

Collaborators

[object Object]
[object Object]